跳至主要内容
临床试验/NL-OMON25963
NL-OMON25963尚未招募不适用

The PROGRAM-study

one0 个研究点目标入组 453 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
one
入组人数
453

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational non invasive

入排标准

入选标准

  • Age =18 years and = 90 years
  • 2.Tumor diagnosed as GBM on MRI as assessed by the neurosurgeon
  • 3.Tumors situated in or near eloquent areas; motor cortex, sensory cortex, subcortical pyramidal tract, speech areas or visual areas as indicated on MRI (Sawaya Grading II and II)
  • 4.The tumor is suitable for resection (according to neurosurgeon)
  • 5.Written informed consent

排除标准

  • 1.Tumors of the cerebellum, brain stem or midline
  • 2.Multifocal contrast enhancing lesions
  • 3.Medical reasons precluding MRI (e.g. pacemaker)
  • 4.Inability to give written informed consent (e.g. because of severe language barrier)
  • 5.Second primary malignancy within the past 5 years with the exception of adequately treated in situ carcinoma of any organ or basal cell carcinoma of the skin

研究者

发起方
one

相似试验